Skip to main content
. 2018 May 3;35(6):545–558. doi: 10.1007/s40266-018-0546-2
Contrary to our hypothesis, patients who received active analgesic treatment had more persistent depressive symptoms
The buprenorphine transdermal system may exacerbate neuropsychiatric symptoms in dementia and should be used with caution in this group